ChitogenX Inc.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regene… Read more
ChitogenX Inc. (CHNXF) - Total Assets
Latest total assets as of October 2024: $385.00K USD
Based on the latest financial reports, ChitogenX Inc. (CHNXF) holds total assets worth $385.00K USD as of October 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ChitogenX Inc. - Total Assets Trend (2019–2024)
This chart illustrates how ChitogenX Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ChitogenX Inc. - Asset Composition Analysis
Current Asset Composition (January 2024)
ChitogenX Inc.'s total assets of $385.00K consist of 43.8% current assets and 56.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.6% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how ChitogenX Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ChitogenX Inc.'s current assets represent 43.8% of total assets in 2024, a decrease from 62.2% in 2019.
- Cash Position: Cash and equivalents constituted 6.6% of total assets in 2024, down from 32.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
ChitogenX Inc. Competitors by Total Assets
Key competitors of ChitogenX Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
ChitogenX Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - ChitogenX Inc. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - ChitogenX Inc. is currently not profitable relative to its asset base.
ChitogenX Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.11 | 3.43 |
| Quick Ratio | 0.01 | 0.11 | 3.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-7.52 Million | $ -3.23 Million | $ 831.00K |
ChitogenX Inc. - Advanced Valuation Insights
This section examines the relationship between ChitogenX Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -27.6% |
| Total Assets | $534.00K |
| Market Capitalization | $91.44K USD |
Valuation Analysis
Below Book Valuation: The market values ChitogenX Inc.'s assets below their book value (0.17 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: ChitogenX Inc.'s assets decreased by 27.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for ChitogenX Inc. (2019–2024)
The table below shows the annual total assets of ChitogenX Inc. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-01-31 | $534.00K | -27.64% |
| 2023-01-31 | $738.00K | -34.28% |
| 2022-01-31 | $1.12 Million | -65.73% |
| 2021-01-31 | $3.28 Million | +154.62% |
| 2020-01-31 | $1.29 Million | -19.75% |
| 2019-01-31 | $1.60 Million | -- |